Updated:
Acquipharma
Acquipharma is led by Oppel Greeff, MD, a former executive at Quintiles Transnational Corporation. Greeff previously served as CEO of Pre-Clinical Development...
Acquipharma
Acquipharma is led by Oppel Greeff, MD, a former executive at Quintiles Transnational Corporation. Greeff previously served as CEO of Pre-Clinical Development and President of Global CRO. Acquipharma has made one investment, in BURL Concepts, as part of their Series B funding round on October 05, 2016.
General information
Firm type
Asset Manager
Location
Region
Africa
Country
South Africa
Corporate office
South Africa
Sector focus
Frequently asked questions
What is Acquipharma?
Acquipharma is a asset manager based in South Africa.
Where is Acquipharma headquartered?
Acquipharma is headquartered in South Africa, in the Africa region.
What does Altss track for Acquipharma?
Altss maintains an OSINT-verified profile of Acquipharma covering investment focus (ESG policy, ticket size, target IRR, currency preference, regional focuses, industry focuses, technological focuses), team (service providers and advisors), deals (company deals and fund commitments), and network (associations and event participation). Detailed values are available to Altss subscribers.
What is Acquipharma's website?
Acquipharma's public website is www.cbinsights.com/investor/acquipharma-holdings. Verified contact details for principals and decision-makers are available to Altss subscribers.
What type of firm is Acquipharma?
Acquipharma is classified by Altss as a Asset Manager, operating from South Africa within the Africa region.
How does Altss source intelligence on Acquipharma?
Altss combines OSINT (open-source intelligence) with regulatory filings, public disclosures, and licensed data partners. Source provenance is tracked to support compliance-ready research workflows.
When was Acquipharma's Altss profile last updated?
Acquipharma's profile on Altss was last refreshed on June 3, 2026. Continuous updates are applied as new public information is verified.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on asset managers?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: